Directing the immune system with neoantigen therapeutics

Date 15 December 2018
Event ESMO Immuno-Oncology Congress 2018
Session Immuno-oncology: State of the art I
Topics Translational Research
Therapy
Presenter Richard Gaynor
Authors R.B. Gaynor
  • Neon Therapeutics, Inc., 02139 - Cambridge/US